SIBO can be diagnosed with the H2 breath test or the so-called Organix urine test. For abdominal complaints, SIBO-specific symptoms, these are the first two tests that are important to perform.
My point of view is that further testing is also needed, especially if these two are negative. Never be satisfied if the doctoris sending you only for a food intolerance test or diagnosing IBS. There is a reason to find outin the background of both.
What are the possible ways for the diagnosis of SIBO
The diagnosis of SIBO is not so simple. The most common tests are the H2 breath test or the so-called Organix urine test. But more tests should be needed to identify the type of SIBO properly.
The tests proposed are therefore as follows:
- SIBO breath test
A synthetic sugar solution should be drunk and then blow at various intervals into a tube connected to a measuring instrument. The test measures the levels of hydrogen and methane in the breath as the sugar solution passes through different parts of the intestines.
Carbohydrates are the number one food source for bacteria and produce hydrogen and methane during the breakdown of carbohydrates. The tests can only be glucose or lactulose tests, depending on the type of sugar solution used. Glucose can only be tested in the initial stages of the gut because it is then absorbed into the body but gives a clear reaction. However, doctors usually require lactulose tests and if it is negative but symptoms are present require a glucose test.
Another kind of diagnosis of SIBO and other possible tests in the case of abdominal issues
- Organix-dysbiosis urine test to diagnose SIBO: Organix Comprehensive Profile can easily identify an overgrowth of yeast and bacteria
- Worm and parasite tests, even for exotic tropical parasites (for example Entamoeba Histolityca), especially if someone travels a lot
- Intestinal microbiome stool test – Comprehensive stool test. This test is a non-invasive diagnostic assessment that allows practitioners to objectively assess the condition of beneficial and pathogenic bacteria, yeast / fungi, and parasites in the gut. Accurate identification of pathogenic species will greatly facilitate the selection of the most appropriate drugs or natural dietary supplements. With Intestinal microbiome test you will see which intestinal bacteria you need to replace, ie what probiotic supplement you should take.)
…. only the tests mentioned above are done then you can do food allergy tests for being able to follow the proper diet.
Five facts about SIBO
Treatment of SIBO
Symptoms and causes of SIBO
Foods in SIBO
SIBO aggravating factors
Resources
[1]
Wijendran V, Huang MC, Diau GY, et al. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr Res 2002;51:265-272.
[2]
Goustard-Langelier B, Guesnet P, Durand G,et al. n-3 and n-6 fatty acid enrichment by dietary $sh oil and phospholipid sources in brain cortical areas and nonneural tissues of formula-fed piglets. Lipids 1999;34:5-16.
[3]
Maki KC, Reeves MS, Farmer M, et al. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res 2009;29:609-615.
[4]
Bunea R, El Farrah K, Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev 2004:9:420-428.
[5]
Sampalis F, Bunea R, Pelland MF, et al. Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Altern Med Rev 2003;8:171-179.
[6]
Deutsch L. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J Am Coll Nutr 2007:26:39-48.
[7]
Chang JP, Chen YT, Su KP. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) in cardiovascular diseases (CVDs) and depression: Cardiovasc Psychiatry Neurol 2009;2009:725310. Epub 2009 Sep 27.
[8]
Breslow J. n-3 fatty acids and cardiovascular disease. Am J Clin Nutr 2006;83:1477S-1482S.
[9]
Calzolari I, Fumagalli S, Marchionni N, DiBari M. Polyunsaturated fatty acids and cardiovascular disease. Curr Pharm Des 2009;15:4094-4102.
[10]
No authors listed. Phosphatidylcholine. Altern Med Rev 2002;7:150-154.
[11]
Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 2000;48:1150-1154.
[12]
Tso P, Drake DS, Black DD, Sabesin SM. Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine. Am J Physiol 1984;247:G599-G610.
[13]
Amate L, Gil A, Ramirez M. Feeding infant piglets formula with long-chain polyunsaturated fatty acids as triacylglycerols or phospholipids influences the distribution of these fatty acids in plasma lipoprotein fractions. J Nutr 2001;131:1250-1255.
[14]
Tandy S, Chung RW, Wat E, et al. Dietary krill oil supplementation reduces hepatic osteatosis, glycemia, and hypercholesterolemia in high-fat-fed mice. J Agric Food Chem 2009;57:9339-9345.
[15]
Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th ed. New York, NY: Garland Science; 2002.
[16]
Else PL, Hulbert AJ. Membranes as metabolic pacemakers. Clin Exp Pharmacol Physiol 2003;30:559-564
[17]
Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. 2007 Sep;12(3):207-27.
[18]
Konagai C, Yanagimoto K, Hayamizu K, Han L, Tsuji T, Koga Y. Effects of krill oil containing n-3 polyunsaturated fatty acids in phospholipid form on human brain function: a randomized controlled trial in healthy elderly volunteers. Clin Interv Aging. 2013;8:1247-57.
[19]
Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, et al. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol. 2009 Jun;64(3):321-7.
[20]
Derosa G, Cicero AF, Fogari E, et al. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load. J Clin Lipidol. 2012 Nov-Dec;6(6):553-64.
[21]
Spencer M, Finlin BS, Unal R, et al. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes. 2013 May;62(5):1709-17.
[22]
Yan Y, Jiang W, Spinetti T, et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013 Jun 27;38(6):1154-63.
[23]
Valensa. FlexPro MD Clinical Trial Overview and Results. (Data on File.) 2011
[24]
McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005;82:281-295.
[25]
Stevens LJ, Zentall SS, Abate ML, et al. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav 1996;59:915-920.
